Filing Flows › BioCorRx (BICX) › Q2 2026 › vs Q1 2026
BioCorRx (BICX) Q2 2026 vs Q1 2026 (quarter over quarter)
BioCorRx's revenue fell $127K (-59%) from $215K in Q1 2026 to $88K in Q2 2026.
BioCorRx, Q2 2026: revenue $88K (-51% year over year), net loss $1.0M, operating cash flow −$440K. The chart draws each line against Q1 2026, the increases inside each band.
Every line
| Line | Q2 2026 | Q1 2026 | Change | % |
|---|---|---|---|---|
| Revenue | $88K | $215K | −$127K | -59% |
| Other income, net | $464K | −$55K | $519K | — |
| Net loss | $1.0M | $1.0M | −$9K | -0.9% |
| Costs & expenses | $1.6M | $1.2M | $328K | +27% |
| Operating costs | $1.6M | $1.2M | $383K | +33% |
| Cost of revenue | $145K | $25K | $120K | +476% |
| Research & development | $712K | $352K | $360K | +102% |
| SG&A | $686K | $775K | −$89K | -11% |
| Other operating costs | $10K | $18K | −$8K | -44% |
| Operating cash sources | $1.0M | $1.0M | −$9K | -0.9% |
| Depreciation & amortization | $10K | $11K | −$1K | -12% |
| Share-based compensation | $122K | $108K | $14K | +13% |
| Working capital & other | $429K | $459K | −$29K | -6% |
| Cash used in operations | $440K | $433K | $7K | +2% |
| Net loss absorbed | $1.0M | $1.0M | −$9K | -0.9% |
Questions
How much did BioCorRx's revenue grow quarter over quarter in Q2 2026?
BioCorRx's revenue fell $127K (-59%) from $215K in Q1 2026 to $88K in Q2 2026.